{"id":52781,"date":"2023-01-11T09:02:19","date_gmt":"2023-01-11T08:02:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/"},"modified":"2023-01-11T09:02:19","modified_gmt":"2023-01-11T08:02:19","slug":"german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/","title":{"rendered":"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Mittelstand companies demonstrate resilience as stubbornly high inflation, energy prices and strained supply chains weigh on the overall business outlook<\/i>\n<\/p>\n<p>FRANKFURT, Germany&#8211;(BUSINESS WIRE)&#8211;Optimism is falling among German Mittelstand leaders, with nearly six in ten (59%) expecting a recession in 2023, and more are feeling pessimistic about the global (24%) and national (28%) economy compared to last year, according to J.P. Morgan\u2019s third annual <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fjpmorgan.com%2Fbusiness-outlook-DEU&amp;esheet=53184937&amp;newsitemid=20230111005044&amp;lan=en-US&amp;anchor=Germany+Business+Leaders+Outlook&amp;index=1&amp;md5=f58993799718c90ba1ec0078f3e173bf\" rel=\"nofollow noopener\" shape=\"rect\">Germany Business Leaders Outlook<\/a> survey released today.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/1680886\/5\/German_BLO_-_1.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/1680886\/21\/German_BLO_-_1.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/652442\/4\/Logo2008_JPM_A_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/652442\/21\/Logo2008_JPM_A_RGB.jpg\"><\/a><\/p>\n<p>\n\u201cAs uncertainties persist into the year ahead, it does not come as a surprise that business leaders have a more subdued outlook on the economy,\u201d said Bernhard Brinker, Head of Commercial Banking, DACH Region, J.P. Morgan. \u201cAt the same time, however, we recognize that Mittelstand companies are resilient and have taken thoughtful precautions to navigate through this uncertain environment.\u201d\n<\/p>\n<p>\nIn a survey of more than 250 senior executives of German Mittelstand companies, many leaders still expect their business to grow in revenue (69%) and profits (59%), though these figures are down 10% and 14% respectively from 2022. More than half (56%) expect capital expenditures to increase, down 10% from 2022, with nearly two out of three expecting capital needs (64%) to also increase.\n<\/p>\n<p>\n\u201cWhile companies are bracing themselves for a harsher business climate, we see that the German Mittelstand community is tackling the economic challenges proactively and continues to have conviction about the strength and success of their businesses,\u201d said Stefan Povaly, Head of Germany, Senior Country Officer, J.P. Morgan.\n<\/p>\n<p>\n<b>Adapting and Solving for Persistent Business Challenges<br \/>\n<br \/><\/b>Business challenges like supply chain issues were evident throughout 2022, with nearly six in ten (57%) leaders citing that supply chain pressures have gotten worse over the past 12 months. To account for this, those experiencing supply chain pressures are allocating more funds to cover increased costs related to moving products (45%), focusing on strategic stockpiling (40%) and are near-shoring by shifting manufacturing or distribution closer to their key markets (39%).\n<\/p>\n<p>\nWhile those experiencing higher costs of doing business cite increased cost of energy (77%) as the biggest driver, nearly a quarter (23%) of Mittelstand leaders see energy prices as the number one external threat or risk to their business.\n<\/p>\n<p>\nNotably, nearly seven in ten (69%) companies still face inflation challenges, and more than half (53%) have raised prices to account for inflation. Of those who have raised prices, the largest share (36%) is passing along 26%-50% of their increased costs on to their consumers. This trend is likely to stay, as a vast majority (83%) of those passing along costs plan to continue to do so.\n<\/p>\n<p>\n<b>Creatively Attracting and Retaining Top Talent<br \/>\n<br \/><\/b>In the midst of continued economic headwinds, 39% of Mittelstand leaders are planning to add headcount and 38% plan to maintain their current headcount in the year ahead.\n<\/p>\n<p>\nIn light of the current labor environment, Mittelstand leaders planning to add or maintain headcount are taking a variety of measures to attract and retain talent through:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nIncreasing wages and benefits (52%)\n<\/li>\n<li>\nOffering flexible work hours (51%)\n<\/li>\n<li>\nOffering upskilling and training opportunities (44%)\n<\/li>\n<li>\nInvesting in automation technology (40%)\n<\/li>\n<\/ul>\n<p>\n<b>Continued Search for Growth as Attitudes Toward Ownership Change<br \/>\n<br \/><\/b>Mittelstand companies continue to look for ways to generate growth and secure the future of their business. When asked about their plans for the next 12 months, almost half of Mittelstand leaders said they are planning to grow their business by expanding into new geographical markets both internationally (43%) and domestically (41%), developing strategic partnerships or investments (42%) and expanding into new distribution channels (41%).\n<\/p>\n<p>\nUnlike previous years, 55% of Mittelstand leaders are not planning to sell or transfer ownership of their company in the next 12 months, up 25% from 2022. Of those who have a transition plan in place, 36% plan to transfer to family through a sale, up 23% from 2022\u2014and notably less (27%) plan to sell to a third party or management group if they\u2019re transferring ownership, down 17% from 2022.\n<\/p>\n<p>\nNearly eight in ten (78%) of those considering a full or partial transfer expect it to take place within the next two years, up 32% from 2022.\n<\/p>\n<p>\n<b>Elevating What Success Looks Like Through Corporate Responsibility<br \/>\n<br \/><\/b>In the year ahead, Mittelstand leaders are focusing on importance of corporate responsibility factors, citing social (56%) and environmental (49%) factors, and governance (48%) as most important to their business strategies\u2014up 15%, 9% and 19% respectively from 2022.\n<\/p>\n<p>\nTop outcomes of these corporate responsibility efforts are rooted in enhancing marketing and finding new customers (54%) and establishing the company\u2019s position within the community (51%).\n<\/p>\n<p>\nFor more information on the 2023 Germany Business Leaders Outlook, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fjpmorgan.com%2Fbusiness-outlook-DEU&amp;esheet=53184937&amp;newsitemid=20230111005044&amp;lan=en-US&amp;anchor=jpmorgan.com%2Fbusiness-outlook-DEU&amp;index=2&amp;md5=5861c8f6f40035711d0d19db46cb795e\" rel=\"nofollow noopener\" shape=\"rect\">jpmorgan.com\/business-outlook-DEU<\/a>.\n<\/p>\n<p>\n<b>Survey Methodology<br \/>\n<br \/><\/b>J. P. Morgan\u2019s German Business Leaders Outlook surveys were conducted online from November 21 \u2013 December 8, 2022. In total, 254 Mittelstand leaders (CEOs, CFOs, heads of finance and owners) from German Mittelstand companies (annual revenues ranging from \u20ac20 million to \u20ac2 billion) across various industries participated in the survey. Results are within statistical parameters for validity, and the error rate is +\/- 6.2% with a 95% confidence level.\n<\/p>\n<p>\n<b>About JPMorgan Chase<br \/>\n<br \/><\/b>JPMorgan Chase &amp; Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (\u201cU.S.\u201d), with operations worldwide. JPMorgan Chase had $3.8 trillion in assets and $288 billion in stockholders\u2019 equity as of September 30, 2022. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world\u2019s most prominent corporate, institutional and government clients globally. Information about JPMorgan Chase &amp; Co. is available at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.jpmorganchase.com%2F&amp;esheet=53184937&amp;newsitemid=20230111005044&amp;lan=en-US&amp;anchor=www.jpmorganchase.com&amp;index=3&amp;md5=46a74d5f132a5a614bcc53b5943e6175\" rel=\"nofollow noopener\" shape=\"rect\">www.jpmorganchase.com<\/a>.\n<\/p>\n<p>\n<i>\u00a9 2023 JPMorgan Chase &amp; Co. All rights reserved. JPMorgan Chase Bank, N.A. Member FDIC. JPMorgan Chase Bank, N.A. is organized under the laws of USA with limited liability. Visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.jpmorgan.com%2Fcommercial-banking%2Flegal-disclaimer&amp;esheet=53184937&amp;newsitemid=20230111005044&amp;lan=en-US&amp;anchor=jpmorgan.com%2Fcb-disclaimer&amp;index=4&amp;md5=6721afb9d8c2e00d3aa0c287e0648fe2\" rel=\"nofollow noopener\" shape=\"rect\">jpmorgan.com\/cb-disclaimer<\/a> for full disclosures and disclaimers related to this content.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Contacts:<\/b><br \/>J.P. Morgan Germany: Kate Haywood, <a target=\"_blank\" href=\"&#109;&#x61;&#x69;&#108;&#x74;&#x6f;&#58;&#x6b;&#x61;&#116;&#x65;&#x2e;&#108;&#x2e;&#x68;&#97;&#x79;&#x77;&#111;&#x6f;&#x64;&#64;&#x6a;&#x70;&#109;&#x6f;&#x72;g&#x61;&#x6e;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;a&#x74;&#101;&#46;&#x6c;&#46;&#x68;&#97;y&#x77;&#111;&#x6f;&#100;&#64;&#x6a;&#112;&#x6d;&#x6f;r&#x67;&#97;n&#x2e;&#99;&#x6f;&#109;<\/a><br \/>J.P. Morgan Commercial Banking: Bentley Weisel, <a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#111;&#x3a;&#x62;&#x65;&#x6e;&#x74;le&#121;&#46;&#114;&#46;&#x77;&#x65;&#x69;&#x73;&#x65;l&#64;&#99;&#104;&#97;&#115;&#x65;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#98;&#101;&#x6e;t&#108;&#x65;&#x79;&#46;&#114;&#x2e;&#x77;e&#105;&#x73;e&#108;&#x40;&#x63;h&#97;&#x73;&#x65;&#46;&#99;&#x6f;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Mittelstand companies demonstrate resilience as stubbornly high inflation, energy prices and strained supply chains weigh on the overall business outlook FRANKFURT, Germany&#8211;(BUSINESS WIRE)&#8211;Optimism is falling among German Mittelstand leaders, with nearly six in ten (59%) expecting a recession in 2023, and more are feeling pessimistic about the global (24%) and national (28%) economy compared to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52781","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Mittelstand companies demonstrate resilience as stubbornly high inflation, energy prices and strained supply chains weigh on the overall business outlook FRANKFURT, Germany&#8211;(BUSINESS WIRE)&#8211;Optimism is falling among German Mittelstand leaders, with nearly six in ten (59%) expecting a recession in 2023, and more are feeling pessimistic about the global (24%) and national (28%) economy compared to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-11T08:02:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/1680886\/21\/German_BLO_-_1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds\",\"datePublished\":\"2023-01-11T08:02:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/\"},\"wordCount\":973,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230111005044\\\/en\\\/1680886\\\/21\\\/German_BLO_-_1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/\",\"name\":\"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230111005044\\\/en\\\/1680886\\\/21\\\/German_BLO_-_1.jpg\",\"datePublished\":\"2023-01-11T08:02:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230111005044\\\/en\\\/1680886\\\/21\\\/German_BLO_-_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230111005044\\\/en\\\/1680886\\\/21\\\/German_BLO_-_1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/","og_locale":"en_US","og_type":"article","og_title":"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds - Pharma Trend","og_description":"Mittelstand companies demonstrate resilience as stubbornly high inflation, energy prices and strained supply chains weigh on the overall business outlook FRANKFURT, Germany&#8211;(BUSINESS WIRE)&#8211;Optimism is falling among German Mittelstand leaders, with nearly six in ten (59%) expecting a recession in 2023, and more are feeling pessimistic about the global (24%) and national (28%) economy compared to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-11T08:02:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/1680886\/21\/German_BLO_-_1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds","datePublished":"2023-01-11T08:02:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/"},"wordCount":973,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/1680886\/21\/German_BLO_-_1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/","url":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/","name":"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/1680886\/21\/German_BLO_-_1.jpg","datePublished":"2023-01-11T08:02:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/1680886\/21\/German_BLO_-_1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230111005044\/en\/1680886\/21\/German_BLO_-_1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/german-mittelstand-leaders-brace-for-recession-while-finding-ways-to-adapt-to-ongoing-business-challenges-third-annual-j-p-morgan-survey-finds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"German Mittelstand Leaders Brace for Recession While Finding Ways to Adapt to Ongoing Business Challenges, Third Annual J.P. Morgan Survey Finds"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52781"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52781\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}